Details for New Drug Application (NDA): 017717
✉ Email this page to a colleague
NDA 017717 describes GYNE-LOTRIMIN, which is a drug marketed by Bayer Healthcare Llc and is included in six NDAs. Additional details are available on the GYNE-LOTRIMIN profile page.
The generic ingredient in GYNE-LOTRIMIN is clotrimazole. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
The generic ingredient in GYNE-LOTRIMIN is clotrimazole. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 017717
| Tradename: | GYNE-LOTRIMIN |
| Applicant: | Bayer Healthcare Llc |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017717
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;VAGINAL | Strength | 100MG | ||||
| Approval Date: | Nov 30, 1990 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
